Cancer Clinical Trials
Cancer clinical trials provide patients with access to new therapies; the next generation of treatment. By joining a trial, you can help move cancer treatment forward and provide real hope for a better future.
In 2015, the Cancer Support Community began an initiative to bring fresh ideas, new language and new approaches to increasing participation in cancer clinical trials by providing a range of resources that speak to a diverse population of cancer patients, caregivers and their health care team in a changing environment.
Check out CSC's Recent Clinical Trials Webinars
The Cancer Support Community hosted webinars on the topic of clinical trials. Watch the videos to learn more.
Watch the webinar, Frankly Speaking About Cancer: Clinical Trials and the Cancer Moonshot that took place on September 29, 2016, for what you need to know about clinical trials and why participating in clinical trials is even more important with the national Cancer Moonshot Initiative.
Do you have an early-stage cancer diagnosis? Are you facing treatment decisions? Consider a clinical trial.
Watch the webinar, Frankly Speaking About Cancer: Clinical Trials for Early-Stage Cancers that took place on October 18, 2016, for what you need to know about early-stage cancer diagnoses and finding clinical trials that might be right for you.
Watch the webinar, Frankly Speaking About Cancer: Clinical Trials and Immunotherapy, that took place on October 24, 2016, for what you need to know about immunotherapy treatment and finding clinical trials that might be right for you. Immunotherapy works by boosting the body’s natural ability to fight cancer.
Watch the webinar, Frankly Speaking About Cancer: Who Is Missing From Cancer Clinical Trials that took place on November 20, 2017. Three advocates will discuss which groups are missing from cancer clinical trials and how we can address this.
Glen lives with prostate and Merkel cell cancer. He joined a clinical trial for prostate cancer when he was first diagnosed to give himself a chance at less side effects than the standard treatment.
Wendy joined a clinical trial for her treatment of triple negative breast cancer. She had worked on clinical trial design as a statistician before she was diagnosed.
Elisa moved from Chile to Chicago to participate in an immunotherapy clinical trial for her metastatic breast cancer.
Mary Clare joined a cancer clinical trial when she was done with treatment to give herself a chance at a longer remission.
Dr. Patricia Robinson, an oncologist, explains some of the different kinds of clinical trials and how clinical trial design is changing with targeted therapies.
Dr. Patricia Robinson, an oncologist, explains some of the barriers that keep patients from joining cancer clinical trials.
Dr. Patricia Robinson, an oncologist, explains why minority participation is so important in clinical trials.